ANG Lifesciences India Ltd
BSE: 540694
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 13.96-38.8% | 22.80+24.6% | 18.30-29.5% | 25.97+5.9% | 24.53+38.9% | 17.67-26.1% | 23.91-25.7% | 32.16 |
| Other Income | 0.19+2.6% | 0.19+19.2% | 0.16-24.2% | 0.21+19.8% | 0.17-76.9% | 0.75+2579.6% | 0.03-92.3% | 0.36 |
| Total Income | 14.15-38.4% | 22.99+24.5% | 18.46-29.5% | 26.18+6.0% | 24.71+34.1% | 18.42-22.9% | 23.88-26.6% | 32.52 |
| EXPENSES | ||||||||
| Expenditure | 18.66-13.4% | 21.56-8.0% | 23.44-12.5% | 26.80+4.1% | 25.73+20.4% | 21.38-27.4% | 29.44-11.3% | 33.19 |
| Tax | -1.09-434.3% | 0.33+144.5% | -0.74-501.6% | 0.18+176.5% | -0.24+76.5% | -1.02-202.3% | 1.00+145.6% | 0.41 |
| PROFIT | ||||||||
| PBT | -4.51-415.6% | 1.43+128.7% | -4.98-706.9% | -0.62+39.9% | -1.03+65.3% | -2.96+46.8% | -5.56-732.6% | -0.67 |
| Net Profit | -3.42-410.0% | 1.10+126.0% | -4.24-430.3% | -0.80-1.6% | -0.79+59.4% | -1.94+57.5% | -4.57-325.0% | -1.07 |
| KEY METRICS | ||||||||
| OPM % | -10.49%-30.75pp | 20.26%+31.60pp | -11.34%-19.87pp | 8.53%+0.98pp | 7.55%+9.59pp | -2.04%+35.97pp | -38.01%-23.94pp | -14.07% |
| NPM % | -24.15%-28.95pp | 4.80%+27.78pp | -22.98%-19.92pp | -3.06%+0.13pp | -3.19%+7.34pp | -10.53%+8.59pp | -19.12%-15.82pp | -3.30% |
| EPS | 2.59+187.8% | 0.90-72.1% | 3.23+438.3% | 0.60+1.7% | 0.59-60.7% | 1.50+142.9% | -3.50-366.7% | -0.75 |
Corporate Events
Board MeetingANG
202614Nov
Board Meeting
To consider and approve the Standalone and Consolidated Un-A…
BSE Filing ↗ Board MeetingANG
202630Sep
Board Meeting
The 20th Annual General Meeting (AGM) of the Shareholders of…
BSE Filing ↗ Board MeetingANG
20267Sep
Board Meeting
The Board of Directors discussed and approved the appointmen…
BSE Filing ↗ Board MeetingANG
202614Aug
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingANG
202630May
Board Meeting
To consider and approve the Standalone and Consolidated Audi…
BSE Filing ↗ Board MeetingANG
202530May
Board Meeting
Consider and approve the Standalone and Consolidated Audited…
BSE Filing ↗